These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7565851)

  • 1. Prevention of remodeling of the heart after myocardial infarction.
    Gorlin R
    Mt Sinai J Med; 1995 Sep; 62(4):287-92. PubMed ID: 7565851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infarction expansion and ventricular remodelling after acute myocardial infarction].
    Høst NB; Hansen PR
    Ugeskr Laeger; 1993 Oct; 155(43):3463-7. PubMed ID: 8256336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibitors in the treatment of patients with acute myocardial infarct].
    Borghi C; Ambrosioni E
    Ann Ital Med Int; 1995; 10(3):175-87. PubMed ID: 7577315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors in heart failure: a role after myocardial infarction.
    Sharpe N
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S99-104. PubMed ID: 1725054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?].
    Morais J
    Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and prevention of congestive heart failure following myocardial infarction.
    Pfeffer MA; Pfeffer JM; Lamas GA
    Circulation; 1993 May; 87(5 Suppl):IV120-5. PubMed ID: 8485827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular remodeling: pathophysiology and treatment.
    Sharpe N
    Heart Fail Monit; 2003; 4(2):55-61. PubMed ID: 14724719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
    Nicolosi GL
    Ital Heart J; 2005 Nov; 6 Suppl 7():33S-39S. PubMed ID: 16485515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic treatment of acute myocardial infarction: 2 large clinical trials at a central hospital].
    Fernando PB; Ferreira A; Dias P; Moura L; Cortez M; Capucho R; Maciel MJ; Brandão F; Gomes MC
    Rev Port Cardiol; 1996 Sep; 15(9):617-30, 611. PubMed ID: 9081315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.